Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Schellens

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Cancer Treatment Reviews|February 18, 1998
Cisplatin resistance and DNA repairM Crul, J H Schellens, J H Beijnen, et al.
Investigational New Drugs|June 8, 2001
Progress in the development of alternative pharmaceutical formulations of taxanesB Nuijen, M Bouma, J H Schellens, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineW J Loos, G Stoter, J Verweij, et al.
Pharmacological Research|October 21, 1999
P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamilM Verschraagen, C H Koks, J H Schellens, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma). A case report and review of the literatureC M Kruijtzer, J H Beijnen, M Swart, et al.
British Journal of Clinical Pharmacology|June 1, 1990
Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjectsJ H Schellens, J H van der Wart, D D Breimer
Investigational New Drugs|August 25, 2000
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug deliveryH A Bardelmeijer, O van Tellingen, J H Schellens, et al.
Cancer Treatment Reviews|July 9, 1999
Clinical pharmacology of anticancer agents in relation to formulations and administration routesJ M Terwogt, J H Schellens, W W Huinink, et al.
The Annals of Pharmacotherapy|August 6, 2000
Cyclosporine-induced anaphylaxisR A Kuiper, M M Malingré, J H Beijnen, et al.
Journal of Chromatography|June 2, 1993
Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urineJ H Schellens, W Loos, J H Beijnen, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Cancer Treatment Reviews|February 18, 1998
Cisplatin resistance and DNA repairM Crul, J H Schellens, J H Beijnen, et al.
Investigational New Drugs|June 8, 2001
Progress in the development of alternative pharmaceutical formulations of taxanesB Nuijen, M Bouma, J H Schellens, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineW J Loos, G Stoter, J Verweij, et al.
Pharmacological Research|October 21, 1999
P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamilM Verschraagen, C H Koks, J H Schellens, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma). A case report and review of the literatureC M Kruijtzer, J H Beijnen, M Swart, et al.
British Journal of Clinical Pharmacology|June 1, 1990
Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjectsJ H Schellens, J H van der Wart, D D Breimer
Investigational New Drugs|August 25, 2000
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug deliveryH A Bardelmeijer, O van Tellingen, J H Schellens, et al.
Cancer Treatment Reviews|July 9, 1999
Clinical pharmacology of anticancer agents in relation to formulations and administration routesJ M Terwogt, J H Schellens, W W Huinink, et al.
The Annals of Pharmacotherapy|August 6, 2000
Cyclosporine-induced anaphylaxisR A Kuiper, M M Malingré, J H Beijnen, et al.
Journal of Chromatography|June 2, 1993
Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urineJ H Schellens, W Loos, J H Beijnen, et al.
Pageof 14